AUSTIN, Texas, Jan. 2, 2013 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX) today announced that management will
present at the 31st Annual JP Morgan Healthcare
Conference to be held January 7 -10,
2013, in San Francisco,
CA.
(Logo:
http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
The investor presentation by Patrick J.
Balthrop, president and chief executive officer, will begin
at 1:30 p.m. Pacific time
(4:30 p.m. Eastern time) on
Wednesday, January 9, 2013. The
presentation will be webcast live and may be accessed at
Luminex Corporation's website at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the
Company section and access the Investor Relations link.
Please go to the website at least 15 minutes prior to the
event to register, download and install any necessary audio/video
software. If you are unable to participate during the live webcast,
the presentation will be archived for six months on the website
using the 'replay' link.
ABOUT LUMINEX CORPORATION
Luminex is committed to
applying its passion for innovation toward advancing healthcare and
research worldwide. The Company is transforming global healthcare
and life-science research through the development, manufacturing
and marketing of proprietary instruments and assays utilizing
xMAP® open-architecture, multi-analyte platform and
MultiCode® real-time polymerase chain reaction (PCR) and
multiplex PCR-based technologies, that deliver cost-effective and
rapid results to clinicians and researchers. Luminex's technology
is commercially available worldwide and in use in leading clinical
laboratories as well as major pharmaceutical, diagnostic,
biotechnology and life-science companies. The Company is meeting
the needs of customers in markets as diverse as clinical
diagnostics, pharmaceutical drug discovery, biomedical research
including genomic and proteomic research, personalized medicine,
bio-defense research and food safety. For further information on
Luminex Corporation and the latest advances in multiplexing using
award winning technology, please visit
http://www.luminexcorp.com.
Contacts:
|
Harriss T.
Currie
|
|
Chief
Financial Officer
|
|
Vice
President Finance
|
|
512-219-8020
|
|
|
|
Matthew
Scalo
|
|
Sr.
Director of Investor Relations
|
|
512-219-8020
|
|
mscalo@luminexcorp.com
|
SOURCE Luminex Corporation